Breaking News

NEW HOPE FOR THALASSAEMIA/SCD | UK Trial Of Lab Grown Red Blood Cells Begins
ADVANCED THERAPIES | Vertex, CRISPR To Submit Exa-Cel to FDA For β-Thalassaemia And Sickle Cell Disease
CDC | Many Children With Sickle Cell Anaemia In The US Not Receiving Lifesaving Screening And Treatment
CLINICAL NEWS | PYRUKYND® Receives Positive CHMP Opinion For The Treatment of PKD in Adults
NEWSLETTER | Iranian Blood Transfusion Organization (IBTO) August 2022
SAFER BLOOD | EU Patients Have Begun Receiving Transfusions With Hemanext ONE® RBC Processing & Storage System
WORLD PATIENT SAFETY DAY 2022 | Medication Without Harm: Know. Check. Ask.
SICKLE CELL DISEASE | African Health Ministers Launch Drive to Curb SCD’s Toll
A HISTORIC BREAKTHROUGH | UNICEF Signs First-Ever Malaria Vaccine Supply Contract With GSK
BREAKING NEWS | Bluebird’s Gene Therapy For β-Thalassaemia Wins US Approval

Français

Menu

Accueil
Qui sommes-nous
Notre activité
Les troubles de l’hémoglobine
Prises de Positions et politiques
Publications
Centre des médias
Nous contacter

Rechercher

Accueil/Centre des médias

Centre des médias

Voir aussi

Twitter updates

Tweets by thalassaemiaTIF

Abonnez-vous à notre chaîne

Instagram updates

Quick links

Per i pazienti
Per gli operatori sanitari
Per le associazioni
Per i sostenitori
Membri della TIF
Link utili
Mappa del sito

TÉLÉCHARGER LES APPLICATIONS

Appli ThaliMe

ABONNEZ-VOUS À NOTRE BULLETIN D’INFORMATION

© Copyright 2024, All Rights Reserved |

Powered by Genestial

Transparency Statement | Privacy Policy

Bouton retour en haut de la page

Fermer

Facebook
X
Linkedin
YouTube
Instagram
RSS

Rechercher :